Puma Biotechnology, Inc. (PBYI)

Last Closing Price: 9.35 (2026-09-01)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Puma Biotechnology, Inc. (PBYI) had Net Income of $8.19M for the most recently reported fiscal quarter, ending 2026-06-30.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
$56.50M
Net Income
$8.19M
$12.47M
$44.03M
$48.92M
$7.58M
$0.66M
$8.24M
$8.24M
$8.19M
$8.19M
$8.19M
$8.19M
$7.58M
$10.10M
50.94M
52.60M
$0.16
$0.16
Balance Sheet Financials
$145.07M
$0.10M
$47.66M
$192.74M
$49.83M
--
$4.37M
$54.19M
$138.54M
$102.02M
$138.54M
51.10M
Cash Flow Statement Financials
$17.04M
$10.45M
$-22.68M
$31.73M
$36.54M
$4.81M
$3.85M
--
--
Fundamental Metrics & Ratios
2.91
--
--
--
--
77.92%
13.42%
13.42%
--
14.59%
14.49%
$17.04M
--
--
--
0.29
0.94
1.66
54.25
5.91%
8.03%
4.25%
5.91%
$2.71
$0.32
$0.32